Lifecore Biomedical, Inc.
LFCR
$4.93
-$0.05-1.00%
NASDAQ
| 03/31/2026 | 09/30/2025 | 05/25/2025 | 05/25/2025 | 02/23/2025 | |
|---|---|---|---|---|---|
| Net Income | -14.98M | -9.99M | -1.15M | -1.15M | -14.77M |
| Total Depreciation and Amortization | 2.31M | 1.98M | 1.91M | 1.91M | 2.08M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.89M | 9.13M | 5.61M | 5.61M | 16.33M |
| Change in Net Operating Assets | 5.48M | 638.00K | -1.03M | -1.03M | -2.44M |
| Cash from Operations | 4.70M | 1.76M | 5.35M | 5.35M | 1.20M |
| Capital Expenditure | -1.12M | -1.74M | -2.10M | -2.10M | -5.46M |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00 | 0.00 | 7.00M |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -1.12M | -1.74M | -2.10M | -2.10M | 1.54M |
| Total Debt Issued | 36.40M | 12.10M | 128.57M | 128.57M | -- |
| Total Debt Repaid | -36.40M | -12.33M | -127.87M | -127.87M | -6.23M |
| Issuance of Common Stock | -- | -- | -- | -- | 17.00K |
| Repurchase of Common Stock | -- | -1.16M | -171.00K | -171.00K | -133.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -256.00K | -- | -930.00K | -930.00K | -435.00K |
| Cash from Financing | -256.00K | -1.39M | -402.00K | -402.00K | -6.78M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.33M | -1.36M | 2.85M | 2.85M | -4.04M |